To examine whether NAFLD was developed due to a HFD and whether PNO had a beneficial influence for the prevention of NAFLD, hepatic fetuin-A mRNA and serum fetuin-A levels were measured. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.